As part of the CPhI webinar series, CAS and IQVIA join forces to deliver insights into optimizing Artificial Intelligence and Machine Learning for predictive analytics, clinical trials and drug discovery in response to COVID-19.
Are you just getting started or ramping up machine learning for chemical and materials research? In this webinar, the panelists will discuss how to prepare for a new informatics project by exploring how to build useful data sets, identify missing capabilities, and communicate expectations.
By any measure, global innovation is accelerating at a dizzying pace. R&D spending, global patent applications, venture capital investment volume, and the pace of technology M&A all reflect the increase in activity.
You May Also Be Interested In...
Articles
Markush structures: Opportunities and risks
Peter Blasi of CAS investigates the pros and cons of scientific intellectual property, specifically thinking about Markush structures and their complications under patent law.
Capitalizing on home grown IP: A deeper look into global tech transfer
Anne Marie Clark of CAS discusses why companies are capitalizing on homegrown intellectual property, and takes a deeper look into the global tech transfer story.